HbA1c levels are associated with chronic kidney disease in a non-diabetic adult population: A nationwide survey (KNHANES 2011-2013)

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Kang, Seok Hui ^a   Jung, Da Jung ^b   Choi, Eun Woo ^a   Cho, Kyu Hyang ^a   Park, Jong Won ^a   Do, Jun Young ^a  

^a Young Nam University Hospital   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CREATININE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELIMINATION PARAMETERS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KOREAN (PEOPLE); MALE; METABOLIC SYNDROME X; REVIEW; SYSTOLIC BLOOD PRESSURE; URINE ALBUMIN CREATININE RATIO; WAIST CIRCUMFERENCE; AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; DISEASE COURSE; INCIDENCE; METABOLISM; MIDDLE AGED; NUTRITION; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; SOUTH KOREA; URINE;

ADULT; AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; CREATININE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION SURVEYS; RENAL INSUFFICIENCY, CHRONIC; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84956937627     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145827     Document Type: Review

References (44)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305. PMID: 15385656
2. Jin DC, Han JS. Renal replacement therapy in Korea, 2012. Kidney Res Clin Pract 2014; 33:9-18.
3. US Renal Data System, USRDS 2014 Annual Data Report: Atlas of Chronic Kidney Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2014.
4. American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care 2015; 38 Suppl 1: S1-S10.
5. Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 2012; 59: 635-643. doi: 10.1016/j.jacc.2011.08.080 PMID: 22322078
6. Osei J, Rhinesmith S, Gaillard T, Schuster D. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patient with type 2 diabetes? J Clin Endocrinol Metab 2003; 88: 4596-4601. PMID: 14557428
7. Ong KL, Tso AW, Lam KS, Cherny SS, Sham PC, Cheung BM. Using glycosylated hemoglobin to define the metabolic syndrome in the United States adults. Diabetes Care 2010; 33: 1856-1858. doi: 10.2337/dc10-0190 PMID: 20504895
8. Park SH, Yoon JS, Won KC, Lee HW. Usefulness of glycated hemoglobin as diagnostic criteria for metabolic syndrome. J Korean Med Sci 2012; 27: 1057-1061. doi: 10.3346/jkms.2012.27.9.1057 PMID: 22969252
9. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174. PMID: 14757614
10. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12. PMID: 19414839
11. Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, et al. Alcohol use. In: Ezzati M, Lopez A, Rodgers A, Murray CJL eds. Comparative Quantification of Health Risks: global and regional burden of disease attributable to selected major risk factors. Geneva, World Health Organization, 2004:959-1108.
12. The Korea Centers for Disease Control and Prevention: Alcohol drinking. [internet]. Available: http://health.mw.go.kr/HealthInfoArea/HealthInfo/View.do?idx=5800&subIdx=3&searchCate=&searchType=&searchKey=&pageNo=&category=&category-code=&dept=&sortType=viewcount&page=1&searchField=&searchWord=.
13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnostic and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112: 2735-2752. PMID: 16157765
14. Alberti KG, Zimmet P, Shaw J. 2005. The metabolic syndrome-a new worldwide definition. Lancet. 366, 1059-1062. PMID: 16182882
15. Kim Y, Je Y. Dairy consumption and risk of metabolic syndrome: a meta-analysis. Diabet Med 2015 Oct 3. doi: 10.1111/dme.12970
16. Johnson DW, Atai E, Chan M, Phoon RK, Scott C, Toussaint ND, et al. KHA-CARI guideline: Early chronic kidney disease: detection, prevention and management. Nephrology 2013; 18:340-50. doi: 10.1111/nep.12052 PMID: 23506545
17. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-72. PMID: 17569110
18. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30:11-21. doi: 10.1002/sim.4085 PMID: 21204120
19. Veeranna V, Ramesh K, Zalawadiya SK, Pradhan J, Jacob S, Afonso L. Glycosylated hemoglobin and prevalent metabolic syndrome in nondiabetic multiethnic U.S. adults. Metab Syndr Relat Disord 2011; 9: 361-367. doi: 10.1089/met.2011.0032 PMID: 21612506
20. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS. Distribution and cardiovascular risk correlates of hemoglobin A(1c) in nondiabetic younger adults: the Bogalusa Heart Study. Metabolism 2008; 57: 1487-1492. doi: 10.1016/j.metabol.2008.04.011 PMID: 18940383
21. Sung KC, Rhee EJ. Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults. Diabet Med 2007; 24: 848-854. PMID: 17650158
22. Dilley J, Ganesan A, Deepa M, Sharada G, Williams OD, Mohan V. Association of A1C with cardiovascular disease and metabolic syndrome in Asian Indians with normal glucose tolerance. Diabetes Care 2007; 30: 1527-1532 PMID: 17351274
23. Kim JH, Choi SR, Lee JR, Shin JH, Lee SJ, Han MA, et al. Association of hemoglobin A1c with cardiovascular disease risk factors and metabolic syndrome in nondiabetic adults. Korean Diabetes J 2008; 32: 435-444.
24. Prasad GV. Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol 2014; 3:210-9. doi: 10.5527/wjn.v3.i4.210 PMID: 25374814
25. Thomas SS, Zhang L, Mitch WE. Molecular mechanisms of insulin resistance in chronic kidney disease. Kidney Int. 2015 Oct 7. doi: 10.1038/ki.2015.305
26. Gerstein HC, Progue J, Mann JF, Lonn E, Dagenais GR, McQueen M, et al. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 2005; 48: 1749-1755. PMID: 16059716
27. Zhang QL, Koenig W, Raum E, Stegmaier C, Brenner H, Rothenbacher D. Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev Med 2009; 48: 122-127. doi: 10.1016/j.ypmed.2008.10.026 PMID: 19041887
28. Plantinga LC, Crews DC, Coresh J, Miller ER 3rd, Saran R, Yee J, et al. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol 2010; 5: 673-682. doi: 10.2215/CJN.07891109 PMID: 20338960
29. Hernandez D, Espejo-Gil A, Bernal-Lopez MR, Mancera-Romero J, Baca-Osorio AJ, Tinahones FJ, et al. Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population. BMC Nephrol 2013; 17: 151.
30. Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care 2005; 28: 2436-2440. PMID: 16186276
31. Selvin E, Ning Y, Steffes MW, Bash LD, Klen R, Wong TY, et al. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 2011; 60: 298-305. doi: 10.2337/db10-1198 PMID: 20978092
32. Schöttker B, Brenner H, Koenig W, Müller H, Rothenbacher D. Prognostic association of HbA1c and fasting plasma glucose with reduced kidney function in subjects with and without diabetes mellitus. Results from a population-based cohort study from Germany. Prev Med 2013; 57: 596-600. doi: 10.1016/j.ypmed.2013.08.002 PMID: 23948106
33. Xing FY, Neeland IJ, Gore MO, Ayers CR, Paixao AR, Turer AT, et al. Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the Dallas Heart Study. Diab Vasc Dis Res 2014; 11: 11-18. doi: 10.1177/1479164113514239 PMID: 24344119
34. Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC. Albuminuria in type 2 (noninsulin- dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 1989; 32:870-6. PMID: 2612758
35. Wiseman M, Viberti G, Mackintosh D, Jarrett RJ, Keen H. Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1984; 26:401-5. PMID: 6468790
36. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-86. PMID: 8366922
37. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359:1577-89. doi: 10.1056/NEJMoa0806470 PMID: 18784090
38. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360:129-39. doi: 10.1056/NEJMoa0808431 PMID: 19092145
39. Perkovic V, Heerspink HL, Chalmers J, Woodward M, Jun M, Li Q, et al. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int. 2013; 83:517-23. doi: 10.1038/ki.2012.401 PMID: 23302714
40. Lim AKh. Diabetic nephropathy-complications and treatment. Int J Nephrol Renovasc Dis 2014; 15:361-81.
41. McNeely MJ, McClelland RL, Bild DE, Jacobs DR Jr, Tracy RP, Cushman M, et al. The association between A1C and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis. Diabetes Care 2009; 32:1727-33. doi: 10.2337/dc09-0074 PMID: 19549732
42. Moebus S, Stang A, Mohlenkamp S, Dragano N, Schmermund A, Slomiany U, et al. Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort-results of the Heinz Nixdorf Recall Study. Diabetologia 2009; 52:81-9. doi: 10.1007/s00125-008-1173-y PMID: 18979083
43. Selvin E, Lazo M, Chen Y, Shen L, Rubin J, McEvoy JW, et al. Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage. Circulation 2014; 130:1374-82. doi: 10.1161/CIRCULATIONAHA.114.010815 PMID: 25149362
44. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3:1-150.